Follow
John Barrett
John Barrett
Chief Stem Cell Transplant Section, Hematology Branch
Verified email at nih.gov
Title
Cited by
Cited by
Year
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs, A Chernoff, N Contentin, E Bahceci, D Schrump, S Leitman, ...
New England Journal of Medicine 343 (11), 750-758, 2000
13322000
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses
R Childs, E Clave, N Contentin, D Jayasekera, N Hensel, S Leitman, ...
Blood, The Journal of the American Society of Hematology 94 (9), 3234-3241, 1999
6771999
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ...
Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002
6642002
Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation
JR Hobbs, AJ Barrett, D Chambers, DCO James, K Hugh-Jones, N Byrom, ...
The Lancet 318 (8249), 709-712, 1981
5931981
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013
5882013
Graft-versus-leukemia reactions in allogeneic chimeras
HJ Kolb, C Schmid, AJ Barrett, DJ Schendel
Blood 103 (3), 767-776, 2004
5452004
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
P Teira, M Battiwalla, M Ramanathan, AJ Barrett, KW Ahn, M Chen, ...
Blood, The Journal of the American Society of Hematology 127 (20), 2427-2438, 2016
5012016
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
K Rezvani, S Mielke, M Ahmadzadeh, Y Kilical, BN Savani, J Zeilah, ...
Blood 108 (4), 1291-1297, 2006
4932006
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
K Rezvani, ASM Yong, S Mielke, BN Savani, L Musse, J Superata, ...
Blood, The Journal of the American Society of Hematology 111 (1), 236-242, 2008
4452008
Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells
J Molldrem, S Dermime, K Parker, YZ Jiang, D Mavroudis, N Hensel, ...
4271996
Hepatitis-associated aplastic anemia
KE Brown, J Tisdale, AJ Barrett, CE Dunbar, NS Young
New England Journal of Medicine 336 (15), 1059-1064, 1997
4121997
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome
M Stetler-Stevenson, DC Arthur, N Jabbour, XY Xie, J Molldrem, ...
Blood, The Journal of the American Society of Hematology 98 (4), 979-987, 2001
3792001
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Y Saunthararajah, R Nakamura, JM Nam, J Robyn, F Loberiza, ...
Blood, The Journal of the American Society of Hematology 100 (5), 1570-1574, 2002
3762002
Antithymocyte globulin for patients with myelodysplastic syndrome
JJ Molldrem, M Caples, D Mavroudis, M Plante, NS Young, AJ Barrett
British journal of haematology 99 (3), 699-705, 1997
3681997
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia
RL Powles, HEM Kay, HM Clink, A Barrett, MH Depledge, J Sloane, ...
The Lancet 321 (8325), 612-615, 1983
3471983
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
EE Solomou, K Rezvani, S Mielke, D Malide, K Keyvanfar, V Visconte, ...
Blood, The Journal of the American Society of Hematology 110 (5), 1603-1606, 2007
3272007
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
JE Levine, T Braun, SL Penza, P Beatty, K Cornetta, R Martino, ...
Journal of Clinical Oncology 20 (2), 405-412, 2002
3202002
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell–depleted hematopoietic allograft
ME Horwitz, AJ Barrett, MR Brown, CS Carter, R Childs, JI Gallin, ...
New England Journal of Medicine 344 (12), 881-888, 2001
3182001
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)
MJ Peckham, A Barrett, KH Liew, A Horwich, B Robinson, HJ Dobbs, ...
British Journal of Cancer 47 (5), 613-619, 1983
3181983
Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units
JJ Molldrem, E Clave, YZ Jiang, D Mavroudis, A Raptis, N Hensel, ...
Blood, The Journal of the American Society of Hematology 90 (7), 2529-2534, 1997
3031997
The system can't perform the operation now. Try again later.
Articles 1–20